Similarly, downregulation of pyruvate dehydrogenase kinase 4 (PDK4) reverted the inhibition of the pyruvate dehydrogenase complex and reduced cell proliferation and tumor volume, potentiating cisplatin effects both in vitro and in vivo [23]. The gene discussed is PDK4; the disease is neoplasm.